Beta-containing COVID-19 booster vaccine found to cross-neutralize
By A Mystery Man Writer
Description
A new paper presents preliminary evidence that a new vaccine candidate, designed to boost immunity in already immunized individuals, and containing the adjuvanted Beta spike variant protein antigen, can induce a potent cross-neutralizing antibody response in non-human primate models that is detectable for up to three months.
Vaccines, Free Full-Text
Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection - ScienceDirect
Vaccines, Free Full-Text
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
Statement on the antigen composition of COVID-19 vaccines
Study shows fully vaccinated individuals preserve cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant
A new variant alert - by Eric Topol - Ground Truths
Omicron booster shots are taking longer than expected. Will the wait be worth it? - The Boston Globe
JCM, Free Full-Text
A Future-Proof Coronavirus Vaccine - McGill University
The COV-BOOST Trial: Safety and Immunogenicity of Boosters - REBEL EM - Emergency Medicine Blog
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
Peptide Products for SARS-CoV-2
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern
from
per adult (price varies by group size)